Tuesday 25 September 2018
Contact US    |    Archive
cnbc.com
12 days ago

JP Morgan says buy Stryker shares because of its new medical technology products

J.P. Morgan reiterates its overweight rating for the Stryker shares, predicting the medical technology company will report earnings above expectations next year.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Morgan

 | 

says

 | 

buy

 | 

Stryker

 | 

shares

 | 

because

 | 

its

 | 

new

 | 

medical

 | 

technology

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)